DK1288208T3 - Fremgangsmåde til fremstilling af 2-(4-alkyl-1-piperazinyl)-benzaldehyd- og -benzylidenforbindelser ved nucleofil aromatisk substituering af 2-flourbenzaldehyd med 4-alkyl-1-peperazin i vand som oplösningsmiddel - Google Patents
Fremgangsmåde til fremstilling af 2-(4-alkyl-1-piperazinyl)-benzaldehyd- og -benzylidenforbindelser ved nucleofil aromatisk substituering af 2-flourbenzaldehyd med 4-alkyl-1-peperazin i vand som oplösningsmiddelInfo
- Publication number
- DK1288208T3 DK1288208T3 DK02255713T DK02255713T DK1288208T3 DK 1288208 T3 DK1288208 T3 DK 1288208T3 DK 02255713 T DK02255713 T DK 02255713T DK 02255713 T DK02255713 T DK 02255713T DK 1288208 T3 DK1288208 T3 DK 1288208T3
- Authority
- DK
- Denmark
- Prior art keywords
- alkyl
- peperazine
- fluorobenzaldehyde
- benzaldehyde
- piperazinyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
- C07D295/112—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
- C07D279/12—1,4-Thiazines; Hydrogenated 1,4-thiazines not condensed with other rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Addiction (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31601001P | 2001-08-30 | 2001-08-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1288208T3 true DK1288208T3 (da) | 2006-10-16 |
Family
ID=23227067
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK02255713T DK1288208T3 (da) | 2001-08-30 | 2002-08-15 | Fremgangsmåde til fremstilling af 2-(4-alkyl-1-piperazinyl)-benzaldehyd- og -benzylidenforbindelser ved nucleofil aromatisk substituering af 2-flourbenzaldehyd med 4-alkyl-1-peperazin i vand som oplösningsmiddel |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US6608195B2 (zh) |
| EP (1) | EP1288208B1 (zh) |
| JP (1) | JP3902751B2 (zh) |
| KR (1) | KR100503518B1 (zh) |
| CN (1) | CN1172920C (zh) |
| AR (1) | AR036373A1 (zh) |
| AT (1) | ATE332897T1 (zh) |
| AU (1) | AU2002300770B2 (zh) |
| BR (1) | BR0203426A (zh) |
| CA (1) | CA2399970A1 (zh) |
| CY (1) | CY1106126T1 (zh) |
| DE (1) | DE60213043T2 (zh) |
| DK (1) | DK1288208T3 (zh) |
| ES (1) | ES2266416T3 (zh) |
| HK (1) | HK1051190A1 (zh) |
| HU (1) | HUP0202907A3 (zh) |
| IL (1) | IL151430A0 (zh) |
| MX (1) | MXPA02008538A (zh) |
| PL (1) | PL355799A1 (zh) |
| PT (1) | PT1288208E (zh) |
| RU (1) | RU2222533C1 (zh) |
| TW (1) | TWI234563B (zh) |
| YU (1) | YU62302A (zh) |
| ZA (1) | ZA200206888B (zh) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050165025A1 (en) * | 2004-01-22 | 2005-07-28 | Recordati Ireland Ltd. | Combination therapy with 5HT 1A and 5HT 1B-receptor antagonists |
| WO2005113526A2 (en) * | 2004-05-21 | 2005-12-01 | Pfizer Products Inc. | Metabolites of 4-(3,4-dichloro-phenyl)-2-[2-(4-methyl-piperazin-1-yl)-benzylidene]-thiomorpholin-3-one |
| CN111269585B (zh) * | 2020-03-11 | 2021-10-08 | 苏州根岸生物科技有限责任公司 | 一种荧光染料及其制备方法与应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA56185C2 (uk) * | 1996-09-30 | 2003-05-15 | Пфайзер Інк. | Аралкіл- та аралкіліденгетероциклічні лактами та іміди, фармацевтична композиція та спосіб лікування |
| US6248888B1 (en) * | 1997-11-14 | 2001-06-19 | Teva Pharmaceutical Industries Ltd. | Process for the preparation of terazosin hydrochloride dihydrate |
| TW426667B (en) | 1997-11-19 | 2001-03-21 | Pfizer | Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance P antagonists |
-
2002
- 2002-08-15 ES ES02255713T patent/ES2266416T3/es not_active Expired - Lifetime
- 2002-08-15 DK DK02255713T patent/DK1288208T3/da active
- 2002-08-15 DE DE60213043T patent/DE60213043T2/de not_active Expired - Fee Related
- 2002-08-15 PT PT02255713T patent/PT1288208E/pt unknown
- 2002-08-15 AT AT02255713T patent/ATE332897T1/de not_active IP Right Cessation
- 2002-08-15 EP EP02255713A patent/EP1288208B1/en not_active Expired - Lifetime
- 2002-08-21 YU YU62302A patent/YU62302A/sh unknown
- 2002-08-22 IL IL15143002A patent/IL151430A0/xx unknown
- 2002-08-26 TW TW091119264A patent/TWI234563B/zh not_active IP Right Cessation
- 2002-08-27 JP JP2002246898A patent/JP3902751B2/ja not_active Expired - Fee Related
- 2002-08-27 CN CNB021418624A patent/CN1172920C/zh not_active Expired - Fee Related
- 2002-08-28 AU AU2002300770A patent/AU2002300770B2/en not_active Ceased
- 2002-08-28 ZA ZA200206888A patent/ZA200206888B/xx unknown
- 2002-08-28 AR ARP020103228A patent/AR036373A1/es unknown
- 2002-08-28 BR BR0203426-3A patent/BR0203426A/pt not_active IP Right Cessation
- 2002-08-28 CA CA002399970A patent/CA2399970A1/en not_active Abandoned
- 2002-08-29 US US10/230,945 patent/US6608195B2/en not_active Expired - Fee Related
- 2002-08-29 MX MXPA02008538A patent/MXPA02008538A/es active IP Right Grant
- 2002-08-29 RU RU2002123289/04A patent/RU2222533C1/ru not_active IP Right Cessation
- 2002-08-29 KR KR10-2002-0051374A patent/KR100503518B1/ko not_active IP Right Cessation
- 2002-08-29 HU HU0202907A patent/HUP0202907A3/hu unknown
- 2002-08-30 PL PL02355799A patent/PL355799A1/xx not_active Application Discontinuation
-
2003
- 2003-05-13 HK HK03103338A patent/HK1051190A1/xx not_active IP Right Cessation
-
2006
- 2006-07-25 CY CY20061101030T patent/CY1106126T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP3902751B2 (ja) | 2007-04-11 |
| KR20030019190A (ko) | 2003-03-06 |
| MXPA02008538A (es) | 2003-03-05 |
| CY1106126T1 (el) | 2011-06-08 |
| CN1403448A (zh) | 2003-03-19 |
| US6608195B2 (en) | 2003-08-19 |
| AU2002300770B2 (en) | 2007-06-07 |
| RU2002123289A (ru) | 2004-03-10 |
| CN1172920C (zh) | 2004-10-27 |
| PT1288208E (pt) | 2006-09-29 |
| US20030087914A1 (en) | 2003-05-08 |
| HU0202907D0 (zh) | 2002-10-28 |
| DE60213043T2 (de) | 2007-01-04 |
| JP2003096060A (ja) | 2003-04-03 |
| HUP0202907A3 (en) | 2004-06-28 |
| DE60213043D1 (de) | 2006-08-24 |
| BR0203426A (pt) | 2003-05-13 |
| HK1051190A1 (en) | 2003-07-25 |
| AR036373A1 (es) | 2004-09-01 |
| TWI234563B (en) | 2005-06-21 |
| EP1288208A1 (en) | 2003-03-05 |
| HUP0202907A2 (hu) | 2003-06-28 |
| EP1288208B1 (en) | 2006-07-12 |
| ATE332897T1 (de) | 2006-08-15 |
| IL151430A0 (en) | 2003-04-10 |
| CA2399970A1 (en) | 2003-02-28 |
| KR100503518B1 (ko) | 2005-07-25 |
| PL355799A1 (en) | 2003-03-10 |
| RU2222533C1 (ru) | 2004-01-27 |
| ZA200206888B (en) | 2004-03-01 |
| ES2266416T3 (es) | 2007-03-01 |
| YU62302A (sh) | 2005-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1651622T3 (da) | Fremgangsmåde til fremstilling af 2-(quinoxalin-5-ylsulfonylamino)-benzamidforbindelser | |
| DK1277722T3 (da) | Fremgangsmåde til fremstilling af methanol | |
| DK1545574T3 (da) | Fremgangsmåde til rensning af polypeptider ved simuleret moving-bed-chromatografi | |
| DK1478358T3 (da) | Sorafenibtosylat til behandling af sygdomme kendetegnet ved unormal angiogenese | |
| DK1828164T3 (da) | Fremgangsmåde til fremstilling af N-phenylpyrazol-1-carboxamider | |
| DK1396483T3 (da) | Fremgangsmåde til fremstilling af dimethylether | |
| DK1647529T3 (da) | Fremgangsmåde til oprensing af spildevand | |
| DK1756049T3 (da) | Fremgangsmåde til fremstilling af 1,4-diphenylazetidinon-derivater | |
| DK1335881T3 (da) | Fremgangsmåde til afsaltning af havvand | |
| DK1536685T3 (da) | Fremgangsmåde til fremstilling af pasta-ekstruderede sulfonamidsammensætninger | |
| DK1309582T3 (da) | Fremgangsmåde til fremstilling af citalopram | |
| DK1831223T3 (da) | Fremgangsmåde til fremstilling af L-biopterin | |
| DK1599455T3 (da) | 4-(3-(2-phenyl-oxazol-4-ylmethoxy)-cyclohexyloxy)-butansyrederivater og beslægtede forbindelser som PPAR modulatorer til behandling af type 2 diabetes og aterosclerose | |
| DK1373255T3 (da) | Fremgangsmåde til fremstilling af imidazolforbindelser | |
| DK1288208T3 (da) | Fremgangsmåde til fremstilling af 2-(4-alkyl-1-piperazinyl)-benzaldehyd- og -benzylidenforbindelser ved nucleofil aromatisk substituering af 2-flourbenzaldehyd med 4-alkyl-1-peperazin i vand som oplösningsmiddel | |
| DK1973563T3 (da) | Fremgangsmåde til oprensning af alfa-1-antitrypsin | |
| DK1756075T3 (da) | Forbindelse til fremstilling af thiazol ved aminomethylering | |
| DK1678135T3 (da) | Fremgangsm de til fremstilling af n-amino-substituerede hetorocykliske forbindelser | |
| DK1390330T3 (da) | Integreret fremgangsmåde til fremstilling af alkyl- og alkenylsubstituerede aromatiske forbindelser | |
| DK1362040T3 (da) | Fremgangsmåde til fremstilling af mesylater af piperidinderivater | |
| DK1656365T3 (da) | Fremgangsmåde til fremstilling af enantiomerisk rent mirtazapin | |
| DK1233961T3 (da) | Fremgangsmåde til fremstilling af 5-(1-piperazinyl)-benzofuran-2-carboxamid ved overgangsmetal-katalyseret aminering | |
| DK1505069T3 (da) | Fremgangsmåde til rensning af moxidectin ved hjælp af krystallisation | |
| DK1127856T3 (da) | Væskekölling af stöbeforme til glasartikler | |
| DK1513653T3 (da) | Patron til optagelse af værktøjer, som anvendes ved at kunne dreje omkring deres akse |